Updated Data of KRSG 1302 Study: Nedaplatin and Nab-Paclitaxel for Patients with Previously Untreated Advanced Squamous Cell Lung Cancer

被引：0
|
作者：
Ohyanagi, F. [1 ]
Nagai, Y. [2 ]
Kasai, T. [2 ]
Koyama, N. [2 ]
Kobayashi, K. [2 ]
Hoshi, E. [2 ]
Nakayama, M. [2 ]
Mori, K. [2 ]
机构：
[1] Jichi Med Univ, Div Pulm Med, Clin Dept Internal Med, Saitama Med Ctr, Saitama, Japan
[2] Kanto Resp Dis Study Grp Krsg, Utsunomiya, Tochigi, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Nedaplatin; nab-Paclitaxel; Squamous Cell Lung Cancer;
D O I：
10.1016/j.jtho.2019.08.1438
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-95
引用
收藏
页码：S678 / S678
页数：1
相关论文
共 50 条
  • [1] A phase II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer (KRSG1302)
    Sugiyama, T.
    Kasai, T.
    Koyama, N.
    Kobayashi, K.
    Hoshi, E.
    Nakayama, M.
    Mori, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302
    Takashi Kasai
    Kiyoshi Mori
    Tomohide Sugiyama
    Nobuyuki Koyama
    Yoichi Nakamura
    Fumiyoshi Ohyanagi
    Hiroki Fukuda
    Eishin Hoshi
    Kunihiko Kobayashi
    Mitsuo Nakayama
    International Journal of Clinical Oncology, 2022, 27 : 1841 - 1848
  • [3] Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302
    Kasai, Takashi
    Mori, Kiyoshi
    Sugiyama, Tomohide
    Koyama, Nobuyuki
    Nakamura, Yoichi
    Ohyanagi, Fumiyoshi
    Fukuda, Hiroki
    Hoshi, Eishin
    Kobayashi, Kunihiko
    Nakayama, Mitsuo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (12) : 1841 - 1848
  • [4] Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non–small cell lung cancer
    Satoshi Igawa
    Sakiko Otani
    Yoshiro Nakahara
    Shinichiro Ryuge
    Yasuhiro Hiyoshi
    Tomoya Fukui
    Hisashi Mitsufuji
    Masaru Kubota
    Masato Katagiri
    Yuichi Sato
    Jiichiro Sasaki
    Noriyuki Masuda
    Investigational New Drugs, 2018, 36 : 45 - 52
  • [5] Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Kim, Young Hak
    Hatachi, Yukimasa
    Fukuhara, Akiko
    Irisa, Kaoru
    Nagai, Hiroki
    Sakamori, Yuichi
    Togashi, Yosuke
    Mio, Tadashi
    Mishima, Michiaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (02) : 325 - 330
  • [6] Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer
    Katsuhiro Masago
    Shiro Fujita
    Young Hak Kim
    Yukimasa Hatachi
    Akiko Fukuhara
    Kaoru Irisa
    Hiroki Nagai
    Yuichi Sakamori
    Yosuke Togashi
    Tadashi Mio
    Michiaki Mishima
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 325 - 330
  • [7] Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer
    Igawa, Satoshi
    Otani, Sakiko
    Nakahara, Yoshiro
    Ryuge, Shinichiro
    Hiyoshi, Yasuhiro
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Kubota, Masaru
    Katagiri, Masato
    Sato, Yuichi
    Sasaki, Jiichiro
    Masuda, Noriyuki
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (01) : 45 - 52
  • [8] Phase III Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
    Nakamura, A.
    Yoneshima, Y.
    Morita, S.
    Ando, M.
    Iwasawa, S.
    Yoshioka, H.
    Goto, Y.
    Takeshita, M.
    Harada, T.
    Hirano, K.
    Oguri, T.
    Kondo, M.
    Miura, S.
    Hosomi, Y.
    Kato, T.
    Kubo, T.
    Kishimoto, J.
    Yamamoto, N.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S107 - S108
  • [9] nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer
    Hirsh, Vera
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (02) : 129 - 141
  • [10] nab-Paclitaxel for the Treatment of Advanced Squamous Non-Small-Cell Lung Cancer: A Comprehensive Update
    Simon, George R.
    CLINICAL LUNG CANCER, 2014, 15 (06) : 391 - 397
12345